LISATA THERAPEUTICS, INC. Unrealized Gain (Loss) on Derivatives
LISATA THERAPEUTICS, INC. (LSTA) reported Unrealized Gain (Loss) on Derivatives of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2016-03-15
- LISATA THERAPEUTICS, INC. unrealized gain (loss) on derivatives for the quarter ending 2015-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. unrealized gain (loss) on derivatives for the quarter ending 2015-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. unrealized gain (loss) on derivatives for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. unrealized gain (loss) on derivatives for the quarter ending 2014-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. unrealized gain (loss) on derivatives for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- LISATA THERAPEUTICS, INC. unrealized gain (loss) on derivatives for fiscal 2014 was $23.18K, a 70.28% decline from fiscal 2013.
- LISATA THERAPEUTICS, INC. unrealized gain (loss) on derivatives for fiscal 2013 was $77.98K, a 79.11% decline from fiscal 2012.
- LISATA THERAPEUTICS, INC. unrealized gain (loss) on derivatives for fiscal 2012 was $373.31K, a 82.20% decline from fiscal 2011.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $23.18K derived: sum of 3 quarters · filed 2016-03-15 | $23.18K 10-K · filed 2016-03-15 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $23.18K derived: sum of 2 quarters · filed 2015-11-05 | $23.18K 10-Q · filed 2015-11-05 | $114.11K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $23.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $23.18K 10-Q · filed 2015-08-06 | $114.11K derived: sum of 3 quarters · filed 2016-03-15 | $32.60K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 | $90.93K derived: sum of 2 quarters · filed 2016-03-15 | $9.43K derived: sum of 3 quarters · filed 2016-03-15 | $67.38K derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $90.93K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $9.43K derived: sum of 2 quarters · filed 2016-03-15 | $67.38K derived: sum of 3 quarters · filed 2016-03-15 | $77.98K 10-K · filed 2016-03-15 |
| 2013-09-30 | -$81.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$23.56K derived: sum of 2 quarters · filed 2014-10-30 | -$12.95K 10-Q · filed 2014-10-30 | $313.44K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $57.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $68.56K 10-Q · filed 2014-08-07 | $394.95K derived: sum of 3 quarters · filed 2015-03-02 | $330.35K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $10.61K 10-Q · filed 2014-05-08 | $337.00K derived: sum of 2 quarters · filed 2015-03-02 | $272.40K derived: sum of 3 quarters · filed 2015-03-02 | $296.62K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $326.40K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $261.79K derived: sum of 2 quarters · filed 2015-03-02 | $286.02K derived: sum of 3 quarters · filed 2015-03-02 | $373.31K 10-K · filed 2015-03-02 |
| 2012-09-30 | -$64.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$40.38K derived: sum of 2 quarters · filed 2013-11-07 | $46.91K 10-Q · filed 2013-11-07 | $482.76K derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-06-30 | $24.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $111.52K 10-Q · filed 2013-08-08 | $547.37K derived: sum of 3 quarters · filed 2013-08-08 | $1.91M derived: sum of 4 quarters · filed 2013-08-08 |
| 2012-03-31 | $87.29K 10-Q · filed 2013-05-09 | $523.15K derived: sum of 2 quarters · filed 2013-05-09 | $1.89M derived: sum of 3 quarters · filed 2013-05-09 | $2.45M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $435.86K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $1.80M derived: sum of 2 quarters · filed 2013-03-11 | $2.36M derived: sum of 3 quarters · filed 2013-03-11 | $2.10M 10-K · filed 2013-03-11 |
| 2011-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $1.92M derived: sum of 2 quarters · filed 2012-11-13 | $1.66M 10-Q · filed 2012-11-13 | |
| 2011-06-30 | $558.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $295.36K 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | -$262.67K 10-Q · filed 2012-05-11 | |||
| 2010-12-31 | -$138.32K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |